Even though the rates of resection with tumor-free margins have improved with more aggressive surgical approaches and improved radiologic techniques, recurrence rates remain high (49%-64%). These recurrences usually occur within 2-3 years post-resection and are predominantly intrahepatic.
Even after curative-intent resection of intrahepatic cholangiocarcinoma, the probability of cure is only about 10%. Up to 45% of patients with cholangiocarcinoma that is considered resectable actually have unresectable disease upon performance of explorative laparotomy. Contraindications to surgical resection include bilateral, multifocal disease; distant metastases; and comorbidities that increase operative risk.
Learn more about treatment and management in cholangiocarcinoma.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: N. Joseph Espat. Fast Five Quiz: Management of Cholangiocarcinoma - Medscape - Feb 20, 2020.
Comments